Skip to Content

SANKYO C22 (Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg)

Pill with imprint SANKYO C22 is Yellow, Round and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SANKYO C22

Hydrochlorothiazide and Olmesartan Medoxomil

Imprint:
SANKYO C22
Strength:
12.5 mg / 20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin II inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC):
57664-0758

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide